Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech to Attend the 19th Annual BIO CEO & Investor Conference in New York
09 févr. 2017 09h00 HE | AXIM Biotechnologies, Inc
NEW YORK, Feb. 09, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E. Anastassov,...
Axim-Sapphire_Logo_-04 (1).png
AXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical Clinical Trials Program in Cannabinoid Research and Development for Multiple Indications
26 oct. 2016 09h00 HE | AXIM Biotechnologies, Inc
NEW YORK, Oct. 26, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the Company has...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotechnologies, Inc. CEO to Speak on Emerging Markets and Cannabis Drug Market at Money Show Dallas
19 oct. 2016 09h00 HE | AXIM Biotechnologies, Inc
NEW YORK, Oct. 19, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that its Chief Executive...
AXIM_photo.jpg
AXIM Biotechnologies, Inc. Increases CanChew Cannabidiol (CBD) Gum Donations By 200%, Beneficiaries Include U.S. Veterans and Legacy Customers
11 juil. 2016 09h00 HE | AXIM Biotechnologies, Inc
NEW YORK, July 11, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech), a world leader in hemp cannabinoid research and development, launched the Company’s community outreach and...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech CEO Appointed to American Pain Association Board of Advisors, Addresses American Opioid Abuse Epidemic
31 mars 2016 09h00 HE | AXIM BIOTECHNOLOGIES, INC
NEW YORK, March 31, 2016 (GLOBE NEWSWIRE) -- Dr. George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM® Biotechnologies, Inc. (OTC:AXIM) was recently appointed to the American Pain...
Medical Marijuana Inc Primary
MJNA's Investment Company AXIM Biotech Announces Clinical Trial Launch of MedChew RX for Treatment of Pain and Spasticity in Multiple Sclerosis and Development of Pharmaceutical Cannabis Chewing Gum
13 août 2015 09h00 HE | Medical Marijuana Inc
SAN DIEGO, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is an agricultural hemp industry innovator that sources, evaluates, invests in and acquires value-adding companies...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Presents Patented Cannabinoid Delivery Methods at My Compassion's Chicago Cannabis Conference
29 juil. 2015 09h00 HE | AXIM BIOTECHNOLOGIES, INC
NEW YORK, July 29, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) CEO George E. Anastassov, MD, DDS, MBA, proudly shared the Company's cannabinoid delivery methods – including...
CanChew
Photo Release -- AXIM Biotechnologies, Inc. Supports Adopt-A-Soldier Platoon's Warfighter Independence Weekend
02 juil. 2015 12h08 HE | AXIM BIOTECHNOLOGIES, INC
NEW YORK, July 2, 2015 (GLOBE NEWSWIRE) -- When signing the Clay Hunt Suicide Prevention for American Veterans Act, President Obama called on Americans to, "Reach out and do more with and for our...